• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

曲安奈德在硅油填充眼中的视网膜毒性。

Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.

作者信息

Kivilcim M, Peyman G A, El-Dessouky E S, Kazi A A, Cheema R, Hegazy H

机构信息

LSU Eye Center, Louisiana State University Medical Center School of Medicine, New Orleans, USA.

出版信息

Ophthalmic Surg Lasers. 2000 Nov-Dec;31(6):474-8.

PMID:11095124
Abstract

OBJECTIVE

To determine the retinal toxicity of triamcinolone acetonide at different doses in vitrectomized, silicone-filled rabbit eyes.

MATERIALS AND METHODS

Vitrectomy with silicone oil placement was performed in 32 rabbit eyes. A dosage of 1 mg/0.025 mL, 2 mg/0.05 mL, or 4 mg/0.1 mL of triamcinolone acetonide was injected intravitreally in the study group eyes; the control group received 0.1 mL of sterile saline. Electroretinography and retinal histology were performed to evaluate toxicity.

RESULTS

No retinal toxicity was seen in the groups given 1, 2, and 4 mg of triamcinolone acetonide or in the control group. ERG and histologic sections in all groups were normal. No drug was visible in the vitreous cavity at the end of the 140-day period (average) in eyes injected with 4 mg of triamcinolone acetonide.

CONCLUSIONS

Up to 4 mg of triamcinolone acetonide can be safely injected in silicone-filled, vitrectomized eyes without any significant retinal toxicity.

摘要

目的

确定不同剂量曲安奈德对玻璃体切除联合硅油填充兔眼的视网膜毒性。

材料与方法

对32只兔眼进行玻璃体切除并注入硅油。研究组眼内注射剂量为1mg/0.025mL、2mg/0.05mL或4mg/0.1mL的曲安奈德;对照组接受0.1mL无菌生理盐水。通过视网膜电图和视网膜组织学检查评估毒性。

结果

给予1mg、2mg和4mg曲安奈德的组以及对照组均未观察到视网膜毒性。所有组的视网膜电图和组织学切片均正常。在注射4mg曲安奈德的眼中,140天(平均)结束时玻璃体腔内未见药物。

结论

在玻璃体切除联合硅油填充的眼中,安全注射高达4mg曲安奈德不会产生任何明显的视网膜毒性。

相似文献

1
Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.曲安奈德在硅油填充眼中的视网膜毒性。
Ophthalmic Surg Lasers. 2000 Nov-Dec;31(6):474-8.
2
Retinal toxicity of intravitreal 5-fluorouracil in silicone-filled rabbit eyes.玻璃体腔内注射5-氟尿嘧啶对硅油填充兔眼的视网膜毒性
J Coll Physicians Surg Pak. 2006 May;16(5):351-4.
3
Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit.兔眼玻璃体内高剂量曲安奈德的视网膜毒性
Exp Eye Res. 2007 Feb;84(2):342-8. doi: 10.1016/j.exer.2006.10.006. Epub 2006 Dec 1.
4
Retinal toxicity of intravitreal kenalog in albino rabbits.玻璃体内注射曲安奈德对白化兔的视网膜毒性
Retina. 2007 Jul-Aug;27(6):778-88. doi: 10.1097/IAE.0b013e318030c517.
5
Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.曲安奈德用于硅油填充眼辅助治疗增生性玻璃体视网膜病变:一项随机临床试验
Ophthalmology. 2008 Nov;115(11):1938-43. doi: 10.1016/j.ophtha.2008.05.016. Epub 2008 Jun 26.
6
Evaluation of the toxicity of subretinal triamcinolone acetonide in the rabbit.兔眼视网膜下注射曲安奈德的毒性评估。
Retina. 2006 Sep;26(7):811-7. doi: 10.1097/01.iae.0000244255.22406.2f.
7
Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes.兔眼玻璃体内注射市售的含防腐剂曲安奈德(康宁克通)的长期视网膜毒性。
Invest Ophthalmol Vis Sci. 2007 Jan;48(1):390-5. doi: 10.1167/iovs.06-0145.
8
Neuroprotective effects of intravitreal triamcinolone acetonide and dexamethasone implant in rabbit retinas after pars plana vitrectomy and silicone oil injection.玻璃体腔注射曲安奈德和地塞米松植入物对兔行扁平部玻璃体切割术联合硅油注入术后视网膜的神经保护作用
Retina. 2015 Feb;35(2):364-70. doi: 10.1097/IAE.0000000000000284.
9
Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.玻璃体切除术后黄斑水肿患者玻璃体内注射曲安奈德后的眼压
J Glaucoma. 2007 Mar;16(2):220-4. doi: 10.1097/IJG.0b013e31802d6e16.
10
Evaluation of intravitreal kenalog toxicity in humans.玻璃体内曲安奈德对人体毒性的评估。
Ophthalmology. 2007 Apr;114(4):724-31. doi: 10.1016/j.ophtha.2006.08.044. Epub 2007 Jan 16.

引用本文的文献

1
Preoperative, Intraoperative and Postoperative Corticosteroid Use as an Adjunctive Treatment for Rhegmatogenous Retinal Detachment.术前、术中和术后使用皮质类固醇作为孔源性视网膜脱离的辅助治疗
J Clin Med. 2020 May 21;9(5):1556. doi: 10.3390/jcm9051556.
2
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.玻璃体内注射类固醇与观察治疗视网膜中央静脉阻塞继发黄斑水肿的比较
Cochrane Database Syst Rev. 2015 Sep 9;2015(9):CD007324. doi: 10.1002/14651858.CD007324.pub3.
3
Comparisons of cone electroretinograms after indocyanine green-, brilliant blue G-, or triamcinolone acetonide-assisted macular hole surgery.
吲哚菁绿、亮蓝G或曲安奈德辅助黄斑裂孔手术后的视锥细胞视网膜电图比较
Graefes Arch Clin Exp Ophthalmol. 2014 Sep;252(9):1423-33. doi: 10.1007/s00417-014-2594-6. Epub 2014 Mar 2.
4
Intravitreal steroids for the treatment of retinal diseases.玻璃体内注射类固醇治疗视网膜疾病。
ScientificWorldJournal. 2014 Jan 8;2014:989501. doi: 10.1155/2014/989501. eCollection 2014.
5
Chromovitrectomy: update.铬玻璃体切除术:最新进展
Saudi J Ophthalmol. 2013 Oct;27(4):271-6. doi: 10.1016/j.sjopt.2013.10.004. Epub 2013 Oct 17.
6
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.玻璃体内注射类固醇与观察治疗视网膜中央静脉阻塞继发黄斑水肿的对比
Cochrane Database Syst Rev. 2009 Jan 21(1):CD007324. doi: 10.1002/14651858.CD007324.pub2.
7
Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion.玻璃体内注射曲安奈德治疗视网膜分支静脉阻塞所致黄斑水肿患者。
Kaohsiung J Med Sci. 2006 Jul;22(7):321-30. doi: 10.1016/S1607-551X(09)70318-3.
8
Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density.曲安奈德的载体与视网膜毒性及晶状体密度短暂增加有关。
Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1152-9. doi: 10.1007/s00417-005-0251-9. Epub 2006 Feb 2.
9
Cell viability effects of triamcinolone acetonide and preservative vehicle formulations.曲安奈德和防腐剂载体配方的细胞活力效应
Br J Ophthalmol. 2006 Feb;90(2):233-6. doi: 10.1136/bjo.2005.076190.
10
[Ocular side effects and complications of intravitreal triamcinolone acetonide injection].[玻璃体内注射曲安奈德的眼部副作用及并发症]
Ophthalmologe. 2004 Feb;101(2):121-8. doi: 10.1007/s00347-003-0975-z.